Lopriore P, Palermo G, Meli A, Bellini G, Benevento E, Montano V
Mov Disord Clin Pract. 2024; 11(8):948-965.
PMID: 38943319
PMC: 11329577.
DOI: 10.1002/mdc3.14148.
Rouzier C, Pion E, Chaussenot A, Bris C, Ait-El-Mkadem Saadi S, Desquiret-Dumas V
Ann Clin Transl Neurol. 2024; 11(6):1478-1491.
PMID: 38703036
PMC: 11187946.
DOI: 10.1002/acn3.52062.
Bartman S, Coppotelli G, Ross J
Curr Issues Mol Biol. 2024; 46(3):1987-2026.
PMID: 38534746
PMC: 10969191.
DOI: 10.3390/cimb46030130.
Liu H, Gao M, Sun Q, Chen S, Luo Y, Yang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 48(11):1760-1768.
PMID: 38432868
PMC: 10929950.
DOI: 10.11817/j.issn.1672-7347.2023.220605.
Klemmensen M, Borrowman S, Pearce C, Pyles B, Chandra B
Neurotherapeutics. 2024; 21(1):e00292.
PMID: 38241161
PMC: 10903104.
DOI: 10.1016/j.neurot.2023.10.002.
Polγ coordinates DNA synthesis and proofreading to ensure mitochondrial genome integrity.
Park J, Herrmann G, Mitchell P, Sherman M, Yin Y
Nat Struct Mol Biol. 2023; 30(6):812-823.
PMID: 37202477
PMC: 10920075.
DOI: 10.1038/s41594-023-00980-2.
The Y831C Mutation of the Gene in Dementia.
Borgione E, Lo Giudice M, Santa Paola S, Giuliano M, Lanza G, Cantone M
Biomedicines. 2023; 11(4).
PMID: 37189790
PMC: 10136026.
DOI: 10.3390/biomedicines11041172.
Mitochondria-Related and Gene Variants and Associations with Tumor Characteristics and Patient Survival in Head and Neck Cancer.
Golubickaite I, Ugenskiene R, Bartnykaite A, Poskiene L, Vegiene A, Padervinskis E
Genes (Basel). 2023; 14(2).
PMID: 36833361
PMC: 9956916.
DOI: 10.3390/genes14020434.
Changing faces of mitochondrial disease: autosomal recessive disease mimicking myasthenia gravis and progressive supranuclear palsy.
Elwan M, Schaefer A, Craig K, Hopton S, Falkous G, Blakely E
BMJ Neurol Open. 2022; 4(2):e000352.
PMID: 36518302
PMC: 9743281.
DOI: 10.1136/bmjno-2022-000352.
Mitochondrial DNA Repair in Neurodegenerative Diseases and Ageing.
Bazzani V, Equisoain Redin M, McHale J, Perrone L, Vascotto C
Int J Mol Sci. 2022; 23(19).
PMID: 36232693
PMC: 9569545.
DOI: 10.3390/ijms231911391.
Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.
Abrishamdar M, Jalali M, Farbood Y
Cell Mol Neurobiol. 2022; 43(4):1499-1518.
PMID: 35951210
PMC: 11412433.
DOI: 10.1007/s10571-022-01265-w.
A new pathogenic POLG variant.
Russo S, Shah E, Copeland W, Koenig M
Mol Genet Metab Rep. 2022; 32:100890.
PMID: 35860755
PMC: 9289853.
DOI: 10.1016/j.ymgmr.2022.100890.
Crosslink between mutations in mitochondrial genes and brain disorders: implications for mitochondrial-targeted therapeutic interventions.
Kalra J
Neural Regen Res. 2022; 18(1):94-101.
PMID: 35799515
PMC: 9241418.
DOI: 10.4103/.
A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models.
Lang M, Grunewald A, Pramstaller P, Hicks A, Pichler I
Cell Mol Life Sci. 2022; 79(5):283.
PMID: 35513611
PMC: 9072496.
DOI: 10.1007/s00018-022-04304-3.
Over-Mutated Mitochondrial, Lysosomal and TFEB-Regulated Genes in Parkinson's Disease.
Segur-Bailach E, Ugarteburu O, Tort F, Texido L, Painous C, Compta Y
J Clin Med. 2022; 11(6).
PMID: 35330074
PMC: 8951534.
DOI: 10.3390/jcm11061749.
Neurogenetic disorders across the lifespan: from aberrant development to degeneration.
Hickman R, OShea S, Mehler M, Chung W
Nat Rev Neurol. 2022; 18(2):117-124.
PMID: 34987232
PMC: 10132523.
DOI: 10.1038/s41582-021-00595-5.
Remdesivir triphosphate blocks DNA synthesis and increases exonucleolysis by the replicative mitochondrial DNA polymerase, Pol γ.
Ciesielska E, Kim S, Bisimwa H, Grier C, Rahman M, Young C
Mitochondrion. 2021; 61:147-158.
PMID: 34619353
PMC: 8595818.
DOI: 10.1016/j.mito.2021.09.010.
A case of drug-induced parkinsonism and tardive akathisia with e1143g polymerase γ mutation-innocent bystander or a culprit?.
Idiculla P, Hussain S, Siddiqui J
J Clin Transl Res. 2021; 7(3):297-301.
PMID: 34179544
PMC: 8221753.
Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present.
Qiu J, Kumar K, Watson E, Ahmad K, Sue C, Hayes M
J Mov Disord. 2021; 14(2):157-160.
PMID: 34062649
PMC: 8175819.
DOI: 10.14802/jmd.20159.
Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice.
Lei Y, Martinez C, Torres-Odio S, Bell S, Birdwell C, Bryant J
Sci Adv. 2021; 7(22).
PMID: 34039599
PMC: 8153723.
DOI: 10.1126/sciadv.abe7548.